Eli Lilly and Company
Classification
Public
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
About
About
Eli Lilly and Company is a global pharmaceutical corporation dedicated to discovering, developing, and delivering innovative medicines to improve people's lives around the world. With a legacy spanning over a century, the company remains committed to its core values of excellence, integrity, and respect for people. Eli Lilly focuses on therapeutic areas such as oncology, diabetes, immunology, neuroscience, and cardiovascular diseases, leveraging its expertise in research and development to address unmet medical needs and advance healthcare solutions. Product/Service Line Breakdown: 1. Oncology Therapeutics: Developing novel cancer treatments targeting various types of cancers. 2. Diabetes Care: Providing medications and solutions for the management of diabetes and related complications. 3. Immunology Products: Offering therapies for autoimmune diseases and related disorders. 4. Neuroscience Medications: Developing treatments for neurological conditions, including Alzheimer's disease and migraine. 5. Cardiovascular Pharmaceuticals: Producing medications for heart diseases and related conditions. 6. Animal Health Products: Providing a range of veterinary medicines and services that cater to the well-being of companion animals and livestock.
Keywords
Keywords
Classified
Private